Key points are not available for this paper at this time.
IL-12 is a central cytokine in the activation of inflammation and immunity and in the generation of Th1-type responses. Tumor-associated macrophages (TAM) from mouse and human tumors showed defective production of IL-12. Defective IL-12 production was associated with lack of p50/p65 NF-kappa B activation. TAM produced increased amounts of the immunosuppressive cytokine IL-10. Abs against IL-10 restored the defective capacity of TAM to produce IL-12. Our data suggest that during tumor growth an IL-10-dependent pathway of diversion of macrophage function can be activated into the tumor microenvironment and results in the promotion of the IL-10+ IL-12- phenotype of TAM. Blocking IL-10, as well as other immunosuppressive cytokines present in the tumor microenvironment, such as TGF-beta, may complement therapeutic strategies aimed at activating type I antitumor immune responses.
Building similarity graph...
Analyzing shared references across papers
Loading...
Sica et al. (Sat,) studied this question.
www.synapsesocial.com/papers/6a04dd097664c2ac4b2a233c — DOI: https://doi.org/10.4049/jimmunol.164.2.762
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
Antonio Sica
Alessandra Saccani
Barbara Bottazzi
The Journal of Immunology
KU Leuven
Mario Negri Institute for Pharmacological Research
University of Brescia
Building similarity graph...
Analyzing shared references across papers
Loading...